Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans
about
Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound HealingFluid phase recognition molecules in neutrophil-dependent immune responses.Ficolins do not alter host immune responses to lipopolysaccharide-induced inflammation in vivo.Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis.Association of the FCN2 Gene Single Nucleotide Polymorphisms with Susceptibility to Pulmonary Tuberculosis.Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor.Ficolins and infectious diseases.Human lectins and their roles in viral infections.A journey through the lectin pathway of complement-MBL and beyond.Ficolin-A/2, acting as a new regulator of macrophage polarization, mediates the inflammatory response in experimental mouse colitis.H-ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses.Interaction of lectin pathway of complement-activating pattern recognition molecules with mycobacteria.A single-stranded DNA aptamer against mannose-capped lipoarabinomannan enhances anti-tuberculosis activity of macrophages through downregulation of lipid-sensing nuclear receptor peroxisome proliferator-activated receptor γ expression.Serum opsonin ficolin-A enhances host-fungal interactions and modulates cytokine expression from human monocyte-derived macrophages and neutrophils following Aspergillus fumigatus challenge.Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo.
P2860
Q26866370-718B0535-B21C-4E29-BD33-919595D037ABQ33626308-FB48DF24-4B27-4DDE-8065-A3ECEF2AB93EQ33819173-1F24394E-3D15-47E5-ACAF-DAE7A88C3732Q35597658-5B9909B5-32CF-44B6-86C9-E5B4B37AFD4BQ35778575-1552D183-8F5E-42F4-8FF3-A9EAB348F514Q36029667-0B811A3C-59D1-4BA1-9FFD-4E273172417DQ38180985-4EB24EF2-F654-4A1E-BB64-85B3DB3F9CBDQ38340871-5737FA77-335D-48A6-9C31-1B95FB3D8D09Q38558930-15D60C52-C629-4B22-9ACF-AF9E72851FCAQ38852137-7BF7E954-454F-4615-95C7-4FE84625CDBEQ38858100-420F3753-6F3C-4F74-803E-ACBEB63EF0B5Q38973892-B6183C09-1225-4FEE-BA39-1B5AA347B36AQ40333363-FBC820E2-1859-43E5-A9FC-60B650ECA1E0Q41017422-A4B49888-685D-4D2F-8F93-8DB6D47CF96DQ41760427-F2CE60AB-C4A0-4326-A1DD-EC78D2FD896D
P2860
Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ficolin-2 defends against viru ...... iated with infection in humans
@ast
Ficolin-2 defends against viru ...... iated with infection in humans
@en
Ficolin-2 defends against viru ...... iated with infection in humans
@nl
type
label
Ficolin-2 defends against viru ...... iated with infection in humans
@ast
Ficolin-2 defends against viru ...... iated with infection in humans
@en
Ficolin-2 defends against viru ...... iated with infection in humans
@nl
prefLabel
Ficolin-2 defends against viru ...... iated with infection in humans
@ast
Ficolin-2 defends against viru ...... iated with infection in humans
@en
Ficolin-2 defends against viru ...... iated with infection in humans
@nl
P2093
P2860
P1433
P1476
Ficolin-2 defends against viru ...... iated with infection in humans
@en
P2093
Fengling Luo
Qilong Wang
Xiao-Lian Zhang
Xiaoming Sun
Yanhong Wu
Yubin Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0073859
P407
P577
2013-09-09T00:00:00Z